Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
705 Riley Hospital Dr
Indianapolis, IN 46202Phone+1 317-944-3774Fax+1 317-944-8521
Summary
- Dr. Bradford Miller is a pediatric gastroenterologist in Indianapolis, IN and is affiliated with multiple hospitals in the area, including Indiana University Health University Hospital and Riley Hospital for Children at IU Health. He received his medical degree from University of South Florida Morsani College of Medicine and has been in practice 3 years. He is experienced in pediatric gastroenterology, pediatric feeding and swallowing disorders, pediatric gastrointestinal motility disorders, pediatric hepatology, and pediatric inflammatory bowel disease. He has 3 publications and 10 citings.
Education & Training
Indiana University School of MedicineFellowship, Pediatric Gastroenterology, 2020 - 2023
University of Louisville School of MedicineResidency, Pediatrics, 2017 - 2020
University of South Florida College of MedicineClass of 2017, MD
University of South Florida MCOMMS, 2011 - 2012
Certifications & Licensure
IN State Medical License 2020 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Gastroenterology
Publications & Presentations
PubMed
- 4 citationsChange in Body Mass Index After Breast Reconstruction and Associated Complications.Matthew A Applebaum, Bradford T. Miller, J.J. Lopez, Erin L. Doren, Christine Laronga
Eplasty. 2015-09-28 - 3 citationsThyroid Hormone at Near Physiologic Concentrations Acutely Increases Oxygen Consumption and Extracellular Acidification in LH86 Hepatoma CellsElizabeth A. McAninch, Bradford T. Miller, Cintia B. Ueta, Sungro Jo, Brian W. Kim
Endocrinology. 2015-08-19 - 3 citationsStatins and Downstream Inhibitors of the Isoprenylation Pathway Increase Type 2 Iodothyronine Deiodinase ActivityBradford T. Miller, Cintia B. Ueta, V. Lau, K. G. Jacomino, L. M. Wasserman
Endocrinology. 2012-06-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
